|
|
|
|
|
|
|
Articles by keyword
medicines
As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents — a move that could cost Canadians up to $900 million a year.
EU free trade deal will hike drug prices in N.S. — minister
| 15-November-2012
A concession on drug patents in a free trade deal with the European Union stands to cost Nova Scotians millions, Health and Wellness Minister David Wilson said Wednesday.
TTP: pacientes, patentes, tratados y mercados
| 14-November-2012
Al decir de Hedwing Lindner –socia de Arochi, Marroquín&Lindner– el Acuerdo Estratégico Transpacífico de Asociación Económica (TPP, por su siglas en inglés) se negocia en lo "oscurito" en materia del capítulo de protección intelectual. Con ello se están protegiendo intereses del sector farmacéutico –al disminuir requisitos formales para otorgar patentes, extenderles vigencia (más de 20 años), aceptar las periféricas o secundarias y rechazar la bioequivalencia– en "detrimento" del desarrollo pleno de la industria nacional. 
Le 23 octobre 2012, le Parlement européen a approuvé l’ACAA, le protocole relatif à l’évaluation de la conformité et l’acceptation des produits industriels UE-Israël. L’ACAA n’est pas un simple accord technique commercial mais un acte politique très important. 
Accord commercial Canada-UE (CETA), Accord de Libre Échange (ALE) UE-Inde, UE-Thaïlande, UE-Moldavie, etc. Tous ces accords contiennent potentiellement des clauses dangereuses pour les libertés des utilisateurs d’Internet, l’accès aux médicaments essentiels ou l’utilisation et la diffusion de logiciels libres. 
Civil society statement calling fpr rejection of the Conformity Assessment and Acceptance of Industrial Products protocol attached to the European Union-Israel Association Agreement 
Les détracteurs des négociations de libre-échange entre le Canada et l’Union européenne crient victoire après la divulgation d’une étude confidentielle fédérale qui conclut que les concessions demandées au Canada dans un seul dossier pourraient coûter près de 2 milliards de plus par année aux Canadiens. 
Although the EU is asking Canada to change its patent regime, it is not possible to do so just for the EU. The actual beneficiaries would be all of the world’s brand-name companies. Of the world’s top 12 health care companies by revenue only three or four are resident in the EU.
HIV patients urge caution on EU FTA talks
| 22-September-2012
People afflicted with the Aids virus have called on the government to proceed carefully on free-trade negotiations with the European Union, as the latter’s demands for copyright protection could make it difficult for patients to access cheap medicines. 
Les négociations sur un accord de libre-échange avec l’Union européenne donnent lieu à un débat au Canada sur la durée de vie des brevets des médicaments, que les grands groupes pharmaceutiques veulent allonger, au grand dam des consommateurs.
Colombia: TLC será el ogro para los medicamentos
| 17-September-2012
Entre un 12% y un 68% crecerá costo de las medicinas por el Tratado de Libre Comercio con Estados Unidos. 
El TLC acordado con Estados Unidos incrementará el número de medicamentos patentados al “relajar los criterios de patentabilidad”. 
Some countries whose governments purchase drugs with a set budget are also alarmed by signs that the TPP may grant new negotiating powers to the industry.
Medicamentos más caros
| 3-September-2012
Los beneficiarios de la salud pública y otros grupos de pacientes en todo el mundo han protestado contra los acuerdos de libre comercio que están negociando Estados Unidos y la Unión Europea con los países en desarrollo, por sus efectos de aumento de los precios de los medicamentos, incluso para enfermedades que suponen riesgo de vida.
Pharma exports: India asks Japan to remove non-tariff barriers
| 2-September-2012
India has asked Japan to remove all non-tax barriers to help the domestic industry take advantage of the comprehensive free-trade agreement and increase share in the Japanese market. 
The letter warns that the TRIPS-Plus provisions in the trade agreement between EU and Thailand – including border measures, data exclusivity, patent term extensions, and protection for new indications – would block access to generic medicines. 
Just Foreign Policy is offering a reward, now up to $21,100, to WikiLeaks if it publishes a draft copy of the TPP. People could add to the reward fund, or if in a position to do so, make a copy of the draft agreement available to the world.
Malaysia says no to TPP
| 7-August-2012
Malaysian Health Minister Datuk Seri Liow Tiong Lai said the Trans-Pacific Partnership Agreement, which is being negotiated among eleven countries including the US and Malaysia, would be detrimental to the local medical industry. 
As the nineteenth International AIDS Conference continued in Washington Tuesday, thousands of protesters marched on the White House calling for an end to free trade deals that protesters argue make vital AIDS medicines unaffordable.
Access to medicines and intellectual property in Jordan
| 23-July-2012
Delayed market entry of generics due to enhanced intellectual property protection cost Jordanian private consumers approximately 18 million US dollars annually |
Court ruling fails to stop business lobbies’ privileged access in EU-India trade talks
| 13-June-2013
|
